Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance — VISION Network, 10 States, December 2021—August 2022

Abstract
Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Britton, A., Embi, P. J., Levy, M. E., Gaglani, M., DeSilva, M. B., Dixon, B. E., Dascomb, K., Patel, P., Schrader, K. E., Klein, N. P., Ong, T. C., Natarajan, K., Hartmann, E., Kharbanda, A. B., Irving, S. A., Dickerson, M., Dunne, M. M., Raiyani, C., Grannis, S. J., … Tenforde, M. W. (2022). Effectiveness of COVID-19 mRNA Vaccines Against COVID-19–Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance—VISION Network, 10 States, December 2021—August 2022. Morbidity and Mortality Weekly Report, 71(42), 1335–1342. https://doi.org/10.15585/mmwr.mm7142a4
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Morbidity and Mortality Weekly Report
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}